FI903752A0 - Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-9-akridinaminderivat. - Google Patents

Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-9-akridinaminderivat.

Info

Publication number
FI903752A0
FI903752A0 FI903752A FI903752A FI903752A0 FI 903752 A0 FI903752 A0 FI 903752A0 FI 903752 A FI903752 A FI 903752A FI 903752 A FI903752 A FI 903752A FI 903752 A0 FI903752 A0 FI 903752A0
Authority
FI
Finland
Prior art keywords
tetrahydro
acridinaminderivat
agents
cerebral
frequency fragmentation
Prior art date
Application number
FI903752A
Other languages
English (en)
Inventor
Colin Granger
Jeffrey Alan Kester
Walter Hamilton Moos
Anthony Jerome Thomas
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI903752A0 publication Critical patent/FI903752A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
FI903752A 1989-07-31 1990-07-27 Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-9-akridinaminderivat. FI903752A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/387,722 US4999430A (en) 1989-07-31 1989-07-31 Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Publications (1)

Publication Number Publication Date
FI903752A0 true FI903752A0 (fi) 1990-07-27

Family

ID=23531113

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903752A FI903752A0 (fi) 1989-07-31 1990-07-27 Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-9-akridinaminderivat.

Country Status (17)

Country Link
US (1) US4999430A (fi)
EP (2) EP0411534B1 (fi)
JP (1) JP2930245B2 (fi)
KR (1) KR910002802A (fi)
AT (2) ATE186908T1 (fi)
AU (1) AU5994590A (fi)
CA (1) CA2022297C (fi)
DE (2) DE69017789T2 (fi)
DK (2) DK0628548T3 (fi)
ES (2) ES2068955T3 (fi)
FI (1) FI903752A0 (fi)
GR (1) GR3032539T3 (fi)
IE (1) IE66823B1 (fi)
NO (1) NO903359L (fi)
NZ (1) NZ234672A (fi)
PT (1) PT94849A (fi)
ZA (1) ZA905978B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25124A (en) * 1987-03-17 1991-02-19 Hoechst Roussel Pharma Substituted 9-amino-tetrahydro acridines and related compounds
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
JP2546919B2 (ja) * 1989-11-08 1996-10-23 三菱化学株式会社 ９ーアシルアミノテトラヒドロアクリジン誘導体
US5179100A (en) * 1992-03-09 1993-01-12 Hoechst-Roussel Pharmaceuticals Inc. 4,5-dihydropyrazolo[3,4-a]acridines
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
HU213107B (en) * 1994-02-23 1997-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing acetic acid derivatives and pharmaceutical compositions containing them
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ES2168926B1 (es) * 1999-12-14 2003-10-16 Prous Science S A Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente.
WO2006004201A1 (ja) * 2004-07-01 2006-01-12 Eisai R & D Management Co., Ltd. 神経再生促進剤
CN1315810C (zh) * 2004-08-30 2007-05-16 北京理工大学 哌嗪桥联他克林双体衍生物及其合成方法
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
US8901129B2 (en) 2009-12-11 2014-12-02 Genecode As Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
ES2881081T3 (es) 2013-03-15 2021-11-26 Agenebio Inc Procedimientos y composiciones para mejorar la función cognitiva
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0319429B1 (en) * 1987-12-03 1994-04-27 Mitsubishi Kasei Corporation 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Also Published As

Publication number Publication date
ATE119885T1 (de) 1995-04-15
DE69033369T2 (de) 2000-05-11
DE69017789T2 (de) 1995-07-13
EP0628548B1 (en) 1999-11-24
AU5994590A (en) 1991-01-31
ATE186908T1 (de) 1999-12-15
JPH0366670A (ja) 1991-03-22
DE69017789D1 (de) 1995-04-20
DK0411534T3 (da) 1995-07-24
NO903359D0 (no) 1990-07-30
KR910002802A (ko) 1991-02-26
ZA905978B (en) 1992-04-29
GR3032539T3 (en) 2000-05-31
IE66823B1 (en) 1996-02-07
ES2068955T3 (es) 1995-05-01
EP0628548A1 (en) 1994-12-14
IE902751A1 (en) 1991-02-27
NZ234672A (en) 1991-11-26
ES2141787T3 (es) 2000-04-01
CA2022297A1 (en) 1991-02-01
EP0411534B1 (en) 1995-03-15
EP0411534A3 (en) 1991-06-05
EP0411534A2 (en) 1991-02-06
US4999430A (en) 1991-03-12
DK0628548T3 (da) 2000-05-08
JP2930245B2 (ja) 1999-08-03
DE69033369D1 (de) 1999-12-30
CA2022297C (en) 2001-09-18
PT94849A (pt) 1991-04-18
NO903359L (no) 1991-02-01

Similar Documents

Publication Publication Date Title
FI903752A0 (fi) Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-9-akridinaminderivat.
AU7217696A (en) New polycyclic aminopyridine compounds which are acetylcholinesterase inhibitors, process for preparing them and their use
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
HUT61753A (en) Process for producing heterocyclene derivatives and pharmaceutical compositions comprising such compounds
AU6001990A (en) 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
CA2019231A1 (en) Novel acetylcholinesterase inhibitors
SI9720060B (en) Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
GEP19991535B (en) Process for the Preparation of 7-Hydroxy Taxanes
GR3006606T3 (fi)
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
MXPA04005139A (es) Derivados de 2 pirrolidin-2-il-iii-indol sustituidos para el tratamiento de migrana.
ES2008421A6 (es) Procedimiento para la obtencion de derivados de la pilocarpina.
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY